Anxiety Medication Overview of Parnate

Parnate, known generically as tranylcypromine, is an antidepressant of the class known as monoamine oxidase inhibitors (MAOIs). It is usually prescribed as a treatment for depression in people who have failed to respond to other more commonly prescribed antidepressants, but it is also prescribed off-label to treat anxiety, panic disorder, and social anxiety disorder.

Parnate is manufactured by GlaxoSmithKline Pharmaceuticals, but a generic version of the drug was approved by the FDA in 2006. The usual dosage of Parnate for anxiety is 30 mg per day, often taken in divided doses.

As with all MAOIs, it is important to be aware of Parnate's potential dangerous interactions with other substances. In addition, to be contraindicated with other MAOIs and certain other prescriptions drugs, MAOIs should not be taken with a number of other substances. These include, but are not limited to, over the counter cold and allergy medications, amphetamines and ephedrine, and foods that are high in tyramine. Foods to be avoided include aged cheeses, cured meats, sour cream, pickled herring, liver, meat prepared with tenderizers, yeast extracts like Marmite, soy sauce, fava beans, canned figs, raisins, avocados, chocolate, and caviar. Alcohol and a large amount of caffeine should also be avoided.

Photo: Px Here

More Articles

Effexor is an antidepressant that has been on the market since 1993. It is a member of the SNRI class of antidepressants (serotonin-norepinephrine...

Depression and anxiety are currently considered as separate disorders. Some people clearly have one or the other, but many people experience an...

Prior research into obsessive-compulsive disorder (OCD) has found it very difficult to conclusively prove the link between hypersensitivity and...

The terms anxiety and stress are often used interchangeably, and it is true that they are related conditions with many of the same symptoms....

In the first study of its kind in this specific patient population, researchers from Columbia University's Mailman School of Public Health found...